- Elite Trade Club
- Posts
- Fashion Stock Starts New Season with 55% Gains
Fashion Stock Starts New Season with 55% Gains
Adam Garcia
May 14, 2025
Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
Rapid Shifts (Sponsored)
Big policy shifts often lead to big market winners. A new investor report reveals 6 stocks positioned to benefit most under the current administration.
These companies could be at the center of capital flows, regulation tailwinds, and sector expansion.
Past picks from this strategy have shown potential for triple-digit gains.
[Download the Report Free]
(By submitting your email, you’ll also get a free Profit from the Pros membership, which highlights exclusive market updates and daily Strong Buy stocks. You can unsubscribe at any time.)
Markets
Wall Street was mixed on Wednesday, as investors adopted a wait-and-see approach after a stellar start to the week. The Nasdaq was the biggest gainer, driven by major tech stocks like Nvidia.
|
|
Market-Moving News
Consumer
Kraft Heinz Makes Biggest Manufacturing Move in a Decade with $3B Spend
Kraft Heinz (NASDAQ: KHC) is investing $3 billion to upgrade its U.S. manufacturing plants, its largest domestic investment in over ten years. The funds will support automation, speed up production, and reduce costs across 30 U.S. facilities that produce core brands like Heinz ketchup, Kraft mac and cheese, and Philadelphia cream cheese.
The initiative comes as the company works to manage inflationary pressures, respond to shifting consumer demand, and navigate new tariff costs.
Executives said the investment will also allow Kraft Heinz to quickly bring new products to market, an increasingly important factor as customer preferences evolve.
For shareholders, this move signals a long-term commitment to operational control and cost discipline, especially during a period of margin pressure.
New investors who seek stability in mature consumer brands look to Kraft Heinz’s focus on domestic production and supply chain resilience, key traits in a volatile pricing environment.
We think this signals confidence from management in the durability of Kraft Heinz’s U.S. business. It also reflects a strategic pivot toward future-proofing operations rather than relying solely on short-term pricing power.
The company expects the upgrade program to create 3,500 construction jobs at its facilities, but does not plan to expand permanent staffing.
Free Report (Sponsored)
Looking for tactical trades with breakout potential?
A newly released investor report reveals 7 stocks that passed a strict screening model for near-term gains.
These stocks are primed to benefit from momentum shifts, strong earnings signals, and institutional tailwinds.
The full list is free to access—but only for a limited time.
[Download the Free Report Now]
*The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research’s newsletter editors and may represent the partial close of a position.
*This free resource is being sent by Zacks. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service".
Pharmaceuticals
Roche Flags $50B U.S. Investment Risk as Industry Reacts to U.S. Prescription Price Crackdown
The pharmaceutical industry is assessing the long-term impact of a new executive order aimed at slashing prescription drug prices in the U.S., with global players warning it could derail major capital investments.
Roche, one of the world's largest drugmakers, indicated that its $50 billion U.S. investment plans could be reconsidered if the policy moves forward.
Such a shift seeks to impose tighter controls on medication costs for American consumers, introducing fresh uncertainty for companies that depend on the U.S. for high-margin product sales.
The United States remains the largest market for many pharma firms, especially those focused on biologics, oncology, and complex therapies.
Roche isn't alone in its exposure. Multiple global firms have announced double-digit billion-dollar investment strategies tied to U.S. production, including recent plant expansions and hiring plans. Depending on how pricing rules are enforced, these strategies may now be subject to delay or revision.
For investors, this development marks a potential shift in how pharmaceutical capital is deployed across markets.
The increased policy risk could lead to slower buildouts, greater emphasis on non-U.S. growth opportunities, and reduced near-term visibility for firms with U.S.-centric models. It also raises questions about future dividend stability and R&D pacing in high-cost categories.
While operational disruption isn't expected in 2025, the industry's message is clear: investment flow could change direction if pricing pressure tightens.
Proven Picks (Sponsored)
What if you could find the next big winner before the crowd?
This just-released report reveals 5 top stocks poised to double—possibly more.
Based on past editions, gains have reached up to +498% and +673%.
Don’t miss your shot—free access ends tonight.
[Claim the Report Now]
*The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research’s newsletter editors and may represent the partial close of a position.
*This free resource is being sent by Zacks. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service".
Media
Warner Bros. Discovery Bets on HBO Max Rebrand to Strengthen Streaming Strategy
Warner Bros. Discovery (NASDAQ: WBD) will rebrand its flagship streaming service to HBO Max this summer to accelerate global expansion. The decision reverses a 2023 move to drop the HBO name and instead leans into its strongest entertainment brand to sharpen positioning in a competitive market.
The rebrand supports WBD’s international growth ambitions, with new launches planned in key markets including the U.K., Germany, Ireland, and Italy. HBO Max will now serve as the unified brand across more than 70 countries where Max is already available.
This marks a shift in strategy, replacing experimentation with brand consolidation as WBD looks to strengthen audience connection and improve retention amid rising churn across the streaming sector.
For investors seeking long-term growth exposure in digital media, the decision highlights WBD’s focus on building a scalable streaming business beyond traditional cable models.
By putting HBO back at the forefront, WBD is reasserting the value of its most trusted IP to boost engagement, simplify marketing efforts, and better compete on a global stage.
WBD ended Q1 with 122.3 million subscribers and expects that number to exceed 150 million by 2026 as international rollouts continue.
Top Winners and Losers
A.K.A. Brands Holding Corp [AKA] $13.90 (+59.77%)
a.k.a. Brands shares rose after the company posted stronger-than-expected revenue growth and raised its full-year outlook, reporting its fourth consecutive quarter of growth.
Newegg Commerce Inc [NEGG] $7.99 (+53.65%)
Newegg stock climbed after announcing it would exclusively launch AMD’s new EPYC 4005 server processors in North America, strengthening its leading position in tech hardware retail.
Septerna Inc [SEPN] $10.04 (+49.18%)
Septerna surged after securing a $2.2 billion licensing deal with Novo Nordisk to co-develop oral obesity and diabetes drugs targeting key metabolic receptors.
Endava Plc ADR [DAVA] $15.65 (-26.90%)
Endava shares dropped after the company lowered its full-year revenue and earnings guidance, citing ongoing macroeconomic uncertainty and a decline in high-spending clients.
Grail Inc [GRAL] $32.89 (-23.32%)
Grail fell after reporting a wider-than-expected quarterly loss of over $100 million, despite strong revenue growth and a new partnership with athenahealth.
Global-E Online Ltd [GLBE] $34.28 (-19.13%)
Global-e shares slipped despite beating revenue and earnings estimates, as investors reacted to mixed segment results and cautious sentiment around profitability.
AI (Sponsored)
AI’s capabilities are growing rapidly—handling layered conversations, correcting itself, and adapting in real time.
This shift is opening up new frontiers for early investors.
A free report just revealed 5 high-potential stocks—including one under-the-radar name with breakout potential.
These tickers are positioned to ride the AI boom in its most advanced form yet.
[See the Top 5 AI Stocks – Free Access]
(By submitting your email address, you will receive a free subscription to the Profit From The Pros e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time.)
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.
